Headache - I don't think Abbott was negotiating those many months with Biocurex, rather wrapping up the blind testing which led to the negotiations for the licensing deal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.